Cargando…
Syntenin Regulated by miR-216b Promotes Cancer Progression in Pancreatic Cancer
Outcomes for patients with pancreatic cancer (PC) are poor; therefore, there is an urgent need to identify novel therapeutic targets involved in the progression of PC. We previously identified 161 differentially expressed proteins (DEPs) in PC. Syntenin (SDCBP) was identified as a survival-related p...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831246/ https://www.ncbi.nlm.nih.gov/pubmed/35155233 http://dx.doi.org/10.3389/fonc.2022.790788 |